Morphine News and Research

Latest Morphine News and Research

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

Bio-Nucleonics' lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer.

28 Jun 2011

FDA approves Lannett's NDA for Morphine Sulfate Oral Solution

Lannett Company, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's 505(b)(2) New Drug Application (NDA) for Morphine Sulfate Oral Solution on June 23, 2011.

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

SNP identification may help predict patients’ susceptibility to postoperative nausea and vomiting

There are several anesthetic complications that may have a hereditary background, including postoperative nausea and vomiting (PONV). Past observations have shown PONV to occur in blood relatives as far back as two to three generations.

23 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011.

8 Jun 2011

FDA issues revised PDUFA date for Lannett's Morphine Sulfate Oral Solution NDA

Lannett Company, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a revised Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2011 for the company's 505(b)(2) New Drug Application for Morphine Sulfate Oral Solution

7 Jun 2011

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Adolor Corporation today announced that it has completed enrollment in its Phase 2 clinical evaluation of ADL5945 in chronic, non-cancer pain patients with opioid-induced constipation (OIC).

6 Jun 2011

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

Novel compound could become an effective alternative to common narcotic analgesics

Scientists from the Florida campus of The Scripps Research Institute have for the first time accomplished a laboratory synthesis of a rare natural product isolated from the bark of a plant widely employed in traditional medicine.

23 May 2011

Pediatric pain experts discuss safety, efficacy of pain medications in children

Can we be certain that pain medications considered safe for adults, based on extensive clinical data and experience, are equally safe for use in young children? Pediatric pain experts discussed this question today in a panel session at the American Pain Society, www.ampainsoc.org, annual scientific meeting and agreed more short term and long-term clinical data are needed to provide assurances about the safety and efficacy of several pain medications in children.

21 May 2011

Patients with sickle cell disease may require higher, frequent doses of morphine

Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.

13 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.

10 May 2011

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL™ will be presented at two medical meetings.

6 May 2011

Marijuana licensing laws vetoed by Washington Governor

Current laws regarding marijuana have come under the scanner. US attorneys have warned states that those who are licensed to grow marijuana or even those who regulate it could be subjected to prosecution. Because of this, several states have begun to change their existing laws for medical marijuana.

4 May 2011

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Aoxing Pharmaceutical, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has been granted a patent by the State Intellectual Property Office of The People's Republic of China for naloxone sublingual film.

3 May 2011

Facts become greatest casualty in war on pain medications

The Florida Society of Pain Management Providers urges Government, Law Enforcement and the media to stop using false prescription drug data and statistics. The continued release of false and / or out of context information is solely intended to enflame the public. The misinformation that unfairly portrays Florida as ground zero in this issue has significant consequences for pain management patients and the physicians who provide legitimate care.

22 Apr 2011

Viewpoints: Gov. Walker on 'obsolete' Medicaid; Are patients consumers?; The Onion pokes fun at Romney

What does Medicaid have in common with "I Dream of Jeannie," "Lost in Space" and "Get Smart"? They all made their debut in 1965. ... the television networks have updated their programming.

22 Apr 2011

NIDA launches Addiction Performance Project for primary care providers

The National Institute on Drug Abuse announced today the launch of its Addiction Performance Project, an innovative continued medical education program designed to help primary care providers break down the stigma associated with addiction.

19 Apr 2011

Morphine News and Research

Latest Morphine News and Research

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

FDA approves Lannett's NDA for Morphine Sulfate Oral Solution

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

SNP identification may help predict patients’ susceptibility to postoperative nausea and vomiting

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

FDA issues revised PDUFA date for Lannett's Morphine Sulfate Oral Solution NDA

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Research provides new understanding of how heroin affects the brain

Novel compound could become an effective alternative to common narcotic analgesics

Pediatric pain experts discuss safety, efficacy of pain medications in children

Patients with sickle cell disease may require higher, frequent doses of morphine

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Marijuana licensing laws vetoed by Washington Governor

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Facts become greatest casualty in war on pain medications

Viewpoints: Gov. Walker on 'obsolete' Medicaid; Are patients consumers?; The Onion pokes fun at Romney

NIDA launches Addiction Performance Project for primary care providers

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Morphine News and Research

Latest Morphine News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in